Publication: Structural basis for substrate specificity of heteromeric transporters of neutral amino acids.
| dc.contributor.author | Rodriguez, Carlos F | |
| dc.contributor.author | Escudero-Bravo, Paloma | |
| dc.contributor.author | Díaz, Lucía | |
| dc.contributor.author | Bartoccioni, Paola | |
| dc.contributor.author | García-Martín, Carmen | |
| dc.contributor.author | Gilabert, Joan G | |
| dc.contributor.author | Boskovic, Jasminka | |
| dc.contributor.author | Guallar, Víctor | |
| dc.contributor.author | Errasti-Murugarren, Ekaitz | |
| dc.contributor.author | Llorca Blanco, Oscar Antonio | |
| dc.contributor.author | Palacín, Manuel | |
| dc.contributor.funder | Wellcome Trust: | es_ES |
| dc.contributor.funder | UK Research and Innovation | |
| dc.contributor.funder | Fundación La Caixa | |
| dc.contributor.funder | Ministerio de Ciencia, Innovación y Universidades (España) | |
| dc.contributor.funder | Instituto de Salud Carlos III | |
| dc.contributor.funder | Unión Europea | |
| dc.date.accessioned | 2024-09-16T08:16:59Z | |
| dc.date.available | 2024-09-16T08:16:59Z | |
| dc.date.issued | 2021-12-07 | |
| dc.description.abstract | Despite having similar structures, each member of the heteromeric amino acid transporter (HAT) family shows exquisite preference for the exchange of certain amino acids. Substrate specificity determines the physiological function of each HAT and their role in human diseases. However, HAT transport preference for some amino acids over others is not yet fully understood. Using cryo-electron microscopy of apo human LAT2/CD98hc and a multidisciplinary approach, we elucidate key molecular determinants governing neutral amino acid specificity in HATs. A few residues in the substrate-binding pocket determine substrate preference. Here, we describe mutations that interconvert the substrate profiles of LAT2/CD98hc, LAT1/CD98hc, and Asc1/CD98hc. In addition, a region far from the substrate-binding pocket critically influences the conformation of the substrate-binding site and substrate preference. This region accumulates mutations that alter substrate specificity and cause hearing loss and cataracts. Here, we uncover molecular mechanisms governing substrate specificity within the HAT family of neutral amino acid transporters and provide the structural bases for mutations in LAT2/CD98hc that alter substrate specificity and that are associated with several pathologies. | es_ES |
| dc.description.peerreviewed | No | es_ES |
| dc.description.sponsorship | The datasets of LAT2/4F2hc used in this study were obtained at the UK National eBIC under Block Allocation Group (BAG) proposal EM20135 (Stop cancer-structural studies of macromolecular com-plexes involved in cancer by cryo-EM) , funded by the Wellcome Trust, Medi-cal Research Council (MRC) , and Biotechnology and Biological Sciences Research Council (BBRSC) , and at the Leicester Institute of Structural and Chemical Biology. We acknowledge the help of Diamond Light Source for access to eBIC and the help of Dr. Christos Savva at Leicester. We thank Nick Berrow (Protein Expression Facility at the Institute for Research in Biomedi-cine (IRB) Barcelona) for the construction of the vectors with the tagged ver-sions of hLAT2 and hCD98hc used in this study. We thank Ismael Mingarro for his help with the calculation of ER membrane insertion of hLAT2 and V460E mutant. We also thank Rafael Fernandez Leiro at Centro Nacional deInvestigaciones Oncologicas (CNIO) for discussions about image processing of the data. This work was funded by "la Caixa" Foundation, Health Research Grant 2020 (LCF/PR/HR20/52400017) to M.P. and O.L.; by the Spanish Ministry of Science, Innovation and Universities (MCIU/AEI) Grants SAF2015-64869-R-FEDER and RTI2018-094211-B-100-FEDER to M.P. and SAF2017-82632-P to O.L.; cofunded by the European Regional Development Fund (ERDF) ; the sup-port of Catalan Government (Grant 2017 SGR 961) to M.P.; the support of the NIH Carlos III to CNIO; Grants Y2018/BIO4747 and P2018/NMT4443 from the Autonomous Region of Madrid and cofunded by the European Social Fundand the ERDF to O.L. C.F.R. is funded by BES-2015-071348 PhD fellowship by the MCIU/AEI. We gratefully acknowledge institutional funding from the Spanish State Research Agency of the Spanish Ministry of Science and Innova-tion-Programa Estatal de Fomento de la Investigacion Cientifica y Tecnica de Excelencia-Centres of Excellence "Severo Ochoa" CEX2019-000891-S and CEX2019-000913-S. IRB Barcelona is a member of the Centres de Recerca de Catalunya (CERCA) System of the Catalan Government. P.B. is supported by a Centro de Investigaci?on Biome?dica en Red de Enfermedades Raras (CIBERER) contract. | es_ES |
| dc.format.number | 49 | es_ES |
| dc.format.volume | 118 | es_ES |
| dc.identifier.citation | Proc Natl Acad Sci U S A . 2021;118(49):e2113573118. | es_ES |
| dc.identifier.doi | 10.1073/pnas.2113573118 | es_ES |
| dc.identifier.e-issn | 1091-6490 | es_ES |
| dc.identifier.journal | Proceedings of the National Academy of Sciences of the United States of America | es_ES |
| dc.identifier.pmc | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670485/pdf/pnas.202113573.pdf | |
| dc.identifier.pubmedID | 34848541 | es_ES |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/23089 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | National Academy of Sciences | |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/SAF2015-64869-R-FEDER | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/RTI2018-094211-B-100-FEDER | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/SAF2017-82632-P | es_ES |
| dc.relation.publisherversion | https://doi.org/10.1073/pnas.2113573118 | es_ES |
| dc.repisalud.institucion | CNIO | es_ES |
| dc.repisalud.orgCNIO | CNIO::Grupos de investigación::Grupo de Complejos Macromoleculares en la Respuesta a Daños en el DNA | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject.mesh | Adaptor Proteins, Signal Transducing | es_ES |
| dc.subject.mesh | Amino Acid Transport Systems | es_ES |
| dc.subject.mesh | Amino Acid Transport Systems, Neutral | es_ES |
| dc.subject.mesh | Amino Acids | es_ES |
| dc.subject.mesh | Amino Acids, Neutral | es_ES |
| dc.subject.mesh | Biological Transport | es_ES |
| dc.subject.mesh | Cryoelectron Microscopy | es_ES |
| dc.subject.mesh | Fusion Regulatory Protein 1, Heavy Chain | es_ES |
| dc.subject.mesh | HeLa Cells | es_ES |
| dc.subject.mesh | Humans | es_ES |
| dc.subject.mesh | Large Neutral Amino Acid-Transporter 1 | es_ES |
| dc.subject.mesh | Protein Domains | es_ES |
| dc.subject.mesh | Structure-Activity Relationship | es_ES |
| dc.subject.mesh | Substrate Specificity | es_ES |
| dc.title | Structural basis for substrate specificity of heteromeric transporters of neutral amino acids. | es_ES |
| dc.type | research article | es_ES |
| dc.type.hasVersion | AM | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 400c30f1-1f41-4b0d-8b2e-327d5b9c3e7e | |
| relation.isAuthorOfPublication | 63cfd8da-7c4d-43c3-a627-57b70f73572a | |
| relation.isAuthorOfPublication.latestForDiscovery | 400c30f1-1f41-4b0d-8b2e-327d5b9c3e7e | |
| relation.isFunderOfPublication | 69c5c2cf-27f2-4969-bdc7-1fd0320137eb | |
| relation.isFunderOfPublication | f04d23ec-a91d-4242-88b0-cc436888f8a2 | |
| relation.isFunderOfPublication | 1aef4c3b-1ee5-4534-83b4-3f3811c67280 | |
| relation.isFunderOfPublication | 7d739953-4b68-4675-b5bb-387a9ab74b66 | |
| relation.isFunderOfPublication | b029ca7c-43c2-46be-af9e-b34b7f455d94 | |
| relation.isFunderOfPublication.latestForDiscovery | 69c5c2cf-27f2-4969-bdc7-1fd0320137eb | |
| relation.isPublisherOfPublication | ae2cc6ce-1cb5-456f-8932-8f02f693fccf | |
| relation.isPublisherOfPublication.latestForDiscovery | ae2cc6ce-1cb5-456f-8932-8f02f693fccf |


